USA: FDA Advisory Committee Advises Pfizer Vaccine For Children 5-11 Years

An advisory committee to the Food and Drug Administration (FDA) of USA recommended this Tuesday the approval of the vaccine against COVID-19 from Pfizer for children between 5 and 11 years old.

After more than seven hours of meeting, the experts of this advisory body gave the green light to the recommendation with 17 votes in favor and one abstention.

The committee had to vote yes or no on the question of whether the benefits of the Pfizer they are higher than the risks in minors between 5 and 11 years old.

Now the FDA it will have to issue its own decision on the matter, which is expected by November 1, and later the Centers for Disease Control and Prevention (CDC, in English) will have to scrutinize the immunization of this age group.

The CDC’s own advisory committee is scheduled to meet on November 2-3 to review vaccine data from Pfizer for children between the ages of 5 and 11, before the director of that agency, Rochelle Walenksy, has the last word on it.

Vaccination against possible dangers

During Tuesday’s session, expert Hong Yang, Risk-Benefit Assessment Advisor for the FDA Office of Biostatistics and Epidemiology, discussed various possible scenarios for the evolution of the pandemic.

In all cases, the benefits of immunizing children “clearly” outweigh the risks, Yang said, citing the myocarditis, an inflammation of the heart, as one of the possible dangers.

On this issue, the expert indicated that, although there is a theoretical risk of myocarditis in boys and that it is more present in vaccinated people, especially in young men, the benefits of being immunized seem to remain “strong.”

A CDC pediatrician, Matthew Oster, who also spoke at the committee meeting, noted that they have not detected higher rates of myocarditis caused by vaccines among children 12 to 17 years old.

In May, the US gave the green light to the Pfizer injection for teens 12 and older.

Oster explained that myocarditis can occur in minors with multisystemic inflammatory syndrome caused by COVID-19.

According to the CDC, although it is unknown what exactly causes this syndrome in which various parts of the body become inflamed, it is known that in many cases it occurs in children who had the COVID-19 or that they were close to a positive for the disease.

The CDC tracked the cases of 5,000 children with this syndrome related to COVID-19 and, according to Oster, the agency “has not yet seen any signs” connecting him to the vaccines.

Specifically, the CDC identified 24 volunteers who had been immunized before contracting the syndrome, of which 18 had been infected with covid.

“We have not seen high rates of MIS-C (as that myocarditis is known) associated with vaccines in infants and older children,” Oster said.

(With information from EFE)

Newsletter All about the coronavirus

The COVID-19 has put everyone on alert. Subscribe to our newsletter All about the coronavirus, where you will find the most relevant daily data in the country and the world on the progress of the virus and the fight against its spread.

Our podcast

Vital Space | Pfizer and BioNTech said a booster shot of their COVID-19 vaccine restored full protection in a large study, results that likely bolster the case for giving a third dose more widely.


Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.